The First Pain & Inflammation Academy In Middle East

Over 180 of the most eminent regional pain and chronic inflammatory disorders management specialists attended the first Middle East Pain & Inflammation Academy. The two day initiative, held on the 12th and 13th of March, 2010, was organized by Pfizer Africa and Middle East and accredited as a Continuous Medical Education (CME) program by the local Dubai Health Authority

The pain and chronic inflammatory disorders management experts – representing medical organizations from the UK, Germany, Canada, UAE and Saudi Arabia – provided workshops, presentations, panel debates and question and answer sessions with senior regional Healthcare Professionals. The key objective of the Pain & Inflammation Academy was to provide a platform to develop strategies aimed at improving the quality of life of pain sufferers.

Among the subjects up for discussion were neuropathic pain (nerve pain), often associated with diabetes, as well as chronic inflammatory disorders such as rheumatoid arthritis and Ankylosing Spondylitis (severe inflammation of the spine and pelvis); and Musculoskeletal pain, such as lower back pain or pain that arises from ankle sprains.

As well as the technical and scientific steps that pain management and inflammation medicine has taken, the academy also looked at the financial and emotional burden of chronic pain and the action needed to enhance quality of life and help family support.

The media were also encouraged to play a part in the academy with a roundtable discussion with the panelists to emphasize the implications of mismanagement of pain and inflammatory disorders.

Share/Save